Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients

According to current guidelines, in chronic lymphocytic leukemia (CLL), only the <i>TP53</i> molecular status must be evaluated prior to every treatment’s initiation. However, additional heterogeneous genetic events are known to confer a proliferative advantage to the tumor clone and are...

Full description

Bibliographic Details
Main Authors: Mariam Ibáñez, Esperanza Such, Alessandro Liquori, Gayane Avestisyan, Rafael Andreu, Ana Vicente, María José Macián, Mari Carmen Melendez, Mireya Morote-Faubel, Pedro Asensi, María Pilar Lloret, Isidro Jarque, Isabel Picón, Alejandro Pacios, Eva Donato, Carmen Mas-Ochoa, Carmen Alonso, Carolina Cañigral, Amparo Sempere, Samuel Romero, Marta Santiago, Guillermo F. Sanz, Javier de la Rubia, Leonor Senent, Irene Luna
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/4/953